Wearable Injectors Market Size

  • Report ID: 3300
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Wearable Injectors Market size was valued at USD 9.54 billion in 2024 and is likely to cross USD 35.35 billion by 2037, expanding at more than 10.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of wearable injectors is estimated at USD 10.4 billion.
 

The growing prevalence of chronic medical conditions and increasing geriatric population, along with the technological developments in drug delivery injectors globally, are expected to fuel the progress of this market in the near future. According to the data collected from Organization for Economic Co-operation & Development (OECD), in 2019, about 33% of the total population of OECD countries aged 15 years and more had two or more chronic conditions, and the number increased to 58% in persons with age more than 65 years. Moreover, the ability of wearable injectors to administer new formulations with higher volume and viscosity can significantly improve the patient experience, which in turn is expected to boost market growth in the coming years. The growth of the market can also be attributed to factors such as the continuous expansion in research for the development of biologics and favorable reimbursement policies for wearable injectors in prominent economic regions.



Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of wearable injectors is estimated at USD 10.4 billion.

Wearable Injectors Market size was valued at USD 9.54 billion in 2024 and is likely to cross USD 35.35 billion by 2037, expanding at more than 10.6% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is set to hold largest revenue share by 2037, owing to large elderly population in many countries of the region such as China and Japan, and the increasing prevalence of chronic disorders in the region.

The major players in the market include Amgen Inc., Insulet Corporation, YPSOMED AG, among others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos